BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34836457)

  • 1. Facial synkinesis: A distressing sequela of facial palsy.
    Shokri T; Patel S; Ziai K; Harounian J; Lighthall JG
    Ear Nose Throat J; 2024 Jun; 103(6):NP382-NP391. PubMed ID: 34836457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of synkinesis.
    Husseman J; Mehta RP
    Facial Plast Surg; 2008 May; 24(2):242-9. PubMed ID: 18470836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic strategies in post-facial paralysis synkinesis in adult patients.
    Terzis JK; Karypidis D
    Plast Reconstr Surg; 2012 Jun; 129(6):925e-939e. PubMed ID: 22634691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategies in post-facial paralysis synkinesis in pediatric patients.
    Terzis JK; Karypidis D
    J Plast Reconstr Aesthet Surg; 2012 Aug; 65(8):1009-18. PubMed ID: 22483723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Neurectomy for Treatment of Post-Facial Paralysis Synkinesis: A Systematic Review.
    Shikara M; Bridgham K; Ludeman E; Vakharia K; Justicz N
    Facial Plast Surg; 2023 Apr; 39(2):190-200. PubMed ID: 36155895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum Toxin in Facial Reanimation: Map of the Facial Musculature and Dosage.
    VandeWater T; Hetzler L
    Atlas Oral Maxillofac Surg Clin North Am; 2023 Mar; 31(1):71-83. PubMed ID: 36754509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective neurectomy for nonflaccid facial palsy.
    Ovaitt AK; Chweya CM; Flynn J
    Curr Opin Otolaryngol Head Neck Surg; 2023 Aug; 31(4):244-247. PubMed ID: 37144494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Changes in the Treatment Pattern of Botulinum Toxin A Injections for Postfacial Paralysis Synkinesis Following Modified Selective Neurectomy.
    Hjelm N; Crippen M; Azizzadeh B
    Facial Plast Surg Aesthet Med; 2021; 23(3):234-235. PubMed ID: 33306003
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemodenervation Algorithm: Functional and Aesthetic Considerations for Facial Harmony in Patients with Post-Facial Paralysis Synkinesis.
    Hetzler L; MacDowell S; Diels J; VandeWater T; Azzizadeh B
    Facial Plast Surg Aesthet Med; 2023; 25(6):512-518. PubMed ID: 37253169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis.
    Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N
    Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latest advances in the management of facial synkinesis.
    Markey JD; Loyo M
    Curr Opin Otolaryngol Head Neck Surg; 2017 Aug; 25(4):265-272. PubMed ID: 28604403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular retraining therapy combined with preceding botulinum toxin A injection for chronic facial paralysis.
    Jeong J; Lee JM; Kim J
    Acta Otolaryngol; 2023 May; 143(5):446-451. PubMed ID: 37173287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Masseteric-to-Facial Nerve Transfer and Selective Neurectomy for Rehabilitation of the Synkinetic Smile.
    Vincent AG; Bevans SE; Robitschek JM; Wind GG; Hohman MH
    JAMA Facial Plast Surg; 2019 Dec; 21(6):504-510. PubMed ID: 31465094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis.
    Patel PN; Owen SR; Norton CP; Emerson BT; Bronaugh AB; Ries WR; Stephan SJ
    JAMA Facial Plast Surg; 2018 May; 20(3):196-201. PubMed ID: 28973100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis.
    Filipo R; Spahiu I; Covelli E; Nicastri M; Bertoli GA
    Laryngoscope; 2012 Feb; 122(2):266-70. PubMed ID: 22252570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Patterns and Outcomes in Botulinum Therapy for Patients With Facial Synkinesis.
    Shinn JR; Nwabueze NN; Du L; Patel PN; Motamedi KK; Norton C; Ries WR; Stephan SJ
    JAMA Facial Plast Surg; 2019 May; 21(3):244-251. PubMed ID: 30703206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Too much or too little? A systematic review of postparetic synkinesis treatment.
    Lapidus JB; Lu JC; Santosa KB; Yaeger LH; Stoll C; Colditz GA; Snyder-Warwick A
    J Plast Reconstr Aesthet Surg; 2020 Mar; 73(3):443-452. PubMed ID: 31786138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platysma synkinesis in facial palsy and botulinum toxin type A.
    Dall'Angelo A; Mandrini S; Sala V; Pavese C; Carlisi E; Comelli M; Toffola ED
    Laryngoscope; 2014 Nov; 124(11):2513-7. PubMed ID: 24764160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term therapy with botulinum toxin in facial synkinesis: Retrospective data analysis of data from 1998 to 2018.
    Alipour S; Pick C; Jansen S; Rink S; Klußmann JP; Grosheva M
    Clin Otolaryngol; 2021 Jul; 46(4):758-766. PubMed ID: 33534183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized management of facial synkinesis based on facial function.
    Maria CM; Kim J
    Acta Otolaryngol; 2017 Sep; 137(9):1010-1015. PubMed ID: 28471705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.